Castle is the latest Resource stock to hit the list, it’s a demerger from former parent company Westgold. The standard 20c buy price is in place as the company looks to raise up to 20M.

CST has a few projects in the Northern Territory at various states of operation, the focus on Gold/Silver etc.

Take a look at the prospectus here.

If resource stocks aren’t your thing then perhaps the latest BioMed offering is of more interest. Nyrada is a pre-clinical biomed focused on cardiovascular, neurodegenerative and chronic inflammatory diseases.

20c is the ask and the company will look to raise 8.5M from the offer. More info available in the prospectus.